229 related articles for article (PubMed ID: 24481757)
41. Evaluation and management of pulmonary nodules: state-of-the-art and future perspectives.
Sayyouh M; Vummidi DR; Kazerooni EA
Expert Opin Med Diagn; 2013 Nov; 7(6):629-44. PubMed ID: 24175679
[TBL] [Abstract][Full Text] [Related]
42. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
[TBL] [Abstract][Full Text] [Related]
43. Protocol considerations for thoracic positron emission tomography-computed tomography.
Shyn PB
Semin Ultrasound CT MR; 2008 Aug; 29(4):242-50. PubMed ID: 18795491
[TBL] [Abstract][Full Text] [Related]
44. Usefulness of contrast-enhanced magnetic resonance imaging for evaluating solitary pulmonary nodules.
Fujimoto K
Cancer Imaging; 2008 Mar; 8(1):36-44. PubMed ID: 18331971
[TBL] [Abstract][Full Text] [Related]
45. Pulmonary nodules: detection, assessment, and CAD.
Girvin F; Ko JP
AJR Am J Roentgenol; 2008 Oct; 191(4):1057-69. PubMed ID: 18806142
[TBL] [Abstract][Full Text] [Related]
46. [CT and MR imaging in the evaluation and staging of lung cancer].
Kuriyama K; Kadota T; Kuroda C
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2140-7. PubMed ID: 2173493
[TBL] [Abstract][Full Text] [Related]
47. Lung carcinoma.
McLoud TC; Swenson SJ
Clin Chest Med; 1999 Dec; 20(4):697-713, vii. PubMed ID: 10587792
[TBL] [Abstract][Full Text] [Related]
48. Considerations for Imaging of Malignant Pleural Mesothelioma: A Consensus Statement from the International Mesothelioma Interest Group.
Katz SI; Straus CM; Roshkovan L; Blyth KG; Frauenfelder T; Gill RR; Lalezari F; Erasmus J; Nowak AK; Gerbaudo VH; Francis RJ; Armato SG
J Thorac Oncol; 2023 Mar; 18(3):278-298. PubMed ID: 36549385
[TBL] [Abstract][Full Text] [Related]
49. Use of computed tomography and positron emission tomography/computed tomography for staging of local extent in patients with malignant pleural mesothelioma.
Frauenfelder T; Kestenholz P; Hunziker R; Nguyen TD; Fries M; Veit-Haibach P; Husmann L; Stahel R; Weder W; Opitz I
J Comput Assist Tomogr; 2015; 39(2):160-5. PubMed ID: 25354093
[TBL] [Abstract][Full Text] [Related]
50. Bilateral thoracoscopy, mediastinoscopy and laparoscopy, in addition to CT, MRI and PET imaging, are essential to correctly stage and treat patients with mesothelioma prior to trimodality therapy.
Alvarez JM; Hasani A; Segal A; Sterret G; Millward M; Nowak A; Musk W; Bydder S
ANZ J Surg; 2009 Oct; 79(10):734-8. PubMed ID: 19878170
[TBL] [Abstract][Full Text] [Related]
51. 18F-FDG PET/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up).
Niccoli-Asabella A; Notaristefano A; Rubini D; Altini C; Ferrari C; Merenda N; Fanelli M; Rubini G
Clin Imaging; 2013; 37(6):1098-103. PubMed ID: 23932389
[TBL] [Abstract][Full Text] [Related]
52. Malignant pleural mesothelioma with heterologous osteoblastic elements: computed tomography, magnetic resonance, and positron emission tomography imaging characteristics of a rare tumor.
Salgado RA; Corthouts R; Parizel PM; Germonpré P; Carp L; Van Schil P; Van Marck E
J Comput Assist Tomogr; 2005; 29(5):653-6. PubMed ID: 16163037
[TBL] [Abstract][Full Text] [Related]
53. Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
Wilcox BE; Subramaniam RM; Peller PJ; Aughenbaugh GL; Nichols Iii FC; Aubry MC; Jett JR
Clin Lung Cancer; 2009 Jul; 10(4):244-8. PubMed ID: 19632941
[TBL] [Abstract][Full Text] [Related]
54. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
[TBL] [Abstract][Full Text] [Related]
55. State-of-the-art MR Imaging for Thoracic Diseases.
Tanaka Y; Ohno Y; Hanamatsu S; Obama Y; Ueda T; Ikeda H; Iwase A; Fukuba T; Hattori H; Murayama K; Yoshikawa T; Takenaka D; Koyama H; Toyama H
Magn Reson Med Sci; 2022 Mar; 21(1):212-234. PubMed ID: 33952785
[TBL] [Abstract][Full Text] [Related]
56. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
[TBL] [Abstract][Full Text] [Related]
57. Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
Pilling J; Dartnell JA; Lang-Lazdunski L
Thorac Cardiovasc Surg; 2010 Jun; 58(4):215-9. PubMed ID: 20514576
[TBL] [Abstract][Full Text] [Related]
58. Computed tomography, positron emission tomography, positron emission tomography/computed tomography, and magnetic resonance imaging for staging of limited pleural mesothelioma: initial results.
Plathow C; Staab A; Schmaehl A; Aschoff P; Zuna I; Pfannenberg C; Peter SH; Eschmann S; Klopp M
Invest Radiol; 2008 Oct; 43(10):737-44. PubMed ID: 18791416
[TBL] [Abstract][Full Text] [Related]
59. Solitary pulmonary nodule: Comparison of quantitative capability for differentiation and management among dynamic CE-perfusion MRI at 3 T system, dynamic CE-perfusion ADCT and FDG-PET/CT.
Ohno Y; Fujisawa Y; Yui M; Takenaka D; Koyama H; Sugihara N; Yoshikawa T
Eur J Radiol; 2019 Jun; 115():22-30. PubMed ID: 31084755
[TBL] [Abstract][Full Text] [Related]
60. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.
Armato SG; Blyth KG; Keating JJ; Katz S; Tsim S; Coolen J; Gudmundsson E; Opitz I; Nowak AK
Lung Cancer; 2016 Nov; 101():48-58. PubMed ID: 27794408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
